173 related articles for article (PubMed ID: 16909969)
41. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
Wilson GD; Dische S; Saunders MI
Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
[TBL] [Abstract][Full Text] [Related]
42. Malignant glioma grade 3 and 4: how relevant is timing of radiotherapy?
Wehming FM; Wiese B; Nakamura M; Bremer M; Karstens JH; Meyer A
Clin Neurol Neurosurg; 2012 Jul; 114(6):617-21. PubMed ID: 22244251
[TBL] [Abstract][Full Text] [Related]
43. Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance.
Michel P; Paresy M; Lepessot F; Hellot MF; Paillot B; Scotte M; Peillon C; Ducrotté P; Hemet J
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):275-80. PubMed ID: 10750646
[TBL] [Abstract][Full Text] [Related]
44. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
45. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
[TBL] [Abstract][Full Text] [Related]
46. Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.
Brada M; Sharpe G; Rajan B; Britton J; Wilkins PR; Guerrero D; Hines F; Traish D; Ashley S
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):287-92. PubMed ID: 10030251
[TBL] [Abstract][Full Text] [Related]
47. Radiation therapy in paediatric gliomas: our institutional experience.
Sharma DN; Goyal SG; Muzumder S; Haresh KP; Bahl A; Julka PK; Rath GK
Neurol Neurochir Pol; 2010; 44(1):28-34. PubMed ID: 20358483
[TBL] [Abstract][Full Text] [Related]
48. Transition from 2D conventional to 3d conformal radiation therapy in patients with brain gliomas: clinical outcome (Mansoura University).
Awad IA; El-Kholi NM; El-Lithy MA; Hendawi EA; Anter AH
J Egypt Natl Canc Inst; 2009 Jun; 21(2):133-8. PubMed ID: 21057564
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
Ohyama S; Yonemura Y; Miyazaki I
Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858
[TBL] [Abstract][Full Text] [Related]
50. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
Lamborn KR; Prados MD; Kaplan SB; Davis RL
Cancer; 1999 Feb; 85(4):925-35. PubMed ID: 10091772
[TBL] [Abstract][Full Text] [Related]
51. Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors.
Chou FF; Eng HL; Sheen-Chen SM
Surgery; 1996 Feb; 119(2):171-7. PubMed ID: 8571202
[TBL] [Abstract][Full Text] [Related]
52. Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapy.
Grabenbauer GG; Roedel CM; Paulus W; Ganslandt O; Schuchardt U; Buchfelder M; Schrell U; Fahlbusch R; Huk WJ; Sauer R
Strahlenther Onkol; 2000 Jun; 176(6):259-64. PubMed ID: 10897252
[TBL] [Abstract][Full Text] [Related]
53. Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade Glioma.
Gzell C; Wheeler H; Huang D; Gaur P; Chen J; Kastelan M; Back M
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):215-22. PubMed ID: 26382848
[TBL] [Abstract][Full Text] [Related]
54. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
55. Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer.
Gasinska A; Skolyszewski J; Popiela T; Richter P; Darasz Z; Nowak K; Niemiec J; Biesaga B; Adamczyk A; Bucki K; Malecki K; Reinfuss M; Kowalska T
J Gastrointest Surg; 2007 Apr; 11(4):520-8. PubMed ID: 17436139
[TBL] [Abstract][Full Text] [Related]
56. Validation of the Medical Research Council and a newly developed prognostic index in patients with malignant glioma: how useful are prognostic indices in routine clinical practice?
Akman F; Cooper RA; Sen M; Tanriver Y; Kentli S
J Neurooncol; 2002 Aug; 59(1):39-47. PubMed ID: 12222837
[TBL] [Abstract][Full Text] [Related]
57. Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas.
Yeh SA; Ho JT; Lui CC; Huang YJ; Hsiung CY; Huang EY
Br J Radiol; 2005 Mar; 78(927):230-5. PubMed ID: 15730987
[TBL] [Abstract][Full Text] [Related]
58. Cellular kinetics in rectal cancer.
Terry NH; Meistrich ML; Roubein LD; Lynch PM; Dubrow RA; Rich TA
Br J Cancer; 1995 Aug; 72(2):435-41. PubMed ID: 7640229
[TBL] [Abstract][Full Text] [Related]
59. Interstitial irradiation of cerebral gliomas with stereotactically implanted iodine-125 seeds.
Voges J; Treuer H; Schlegel W; Pastyr O; Sturm V
Acta Neurochir Suppl (Wien); 1993; 58():108-11. PubMed ID: 8109270
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
